Table III.
Comparisons of clinical data between PCOS group complicated with NAFLD and control group complicated with NAFLD.
| Index | Control group complicated with NAFLD (n=16) | PCOS group complicated with NAFLD (n=84) | P-value |
|---|---|---|---|
| Age (years) | 27.46±4.49 | 27.32±6.15 | 0.057 |
| BMI (kg/m2) | 28.92±3.68 | 28.61±4.27 | 0.192 |
| WHR | 0.91±0.07 | 0.94±0.08 | 0.936 |
| LH (IU/l) | 8.41±5.36 | 10.56±9.05 | 0.061 |
| FSH (IU/l) | 7.36±2.79 | 7.13±3.09 | 0.523 |
| LH/FSH | 1.23±0.82 | 1.51±1.14 | 0.109 |
| T (nmol/l) | 1.66±0.93 | 2.17±0.89 | >0.05 |
| DHEAs (µg/dl) | 217.43±115.31 | 219.75±98.46 | 0.962 |
| SHBG (nmol/l)a | 39.89 (22.65–43.13) | 24.16 (18.98–29.34) | 0.002 |
| FAIa | 6.35 (4.31–8.39) | 13.97 (11.61–16.37) | >0.05 |
| FBG (mmol/l) | 4.84±0.43 | 5.02±0.46 | 0.831 |
| FINS (mIU/l)a | 13.21 (11.05–15.38) | 19.71 (16.56–22.82) | 0.027 |
| HOMA-IR | 2.30±0.62 | 4.83±0.84 | >0.05 |
a
Non-normal data.